TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: A proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)

Blood

Volumn 110, Issue 2, 2007, Pages 479-484

  Kim, Youn H ^a   Willemze, Rein ^b   Pimpinelli, Nicola ^c   Whittaker, Sean ^d   Olsen, Elise A ^e   Ranki, Annamari ^f   Dummer, Reinhard ^g   Hoppe, Richard T ^a  

^a STANFORD CANCER INSTITUTE   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF FLORENCE   (Italy)

^d ST THOMAS HOSPITAL   (United Kingdom)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^g UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW BIOPSY; CANCER STAGING; CANCER SURVIVAL; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONSENSUS; CUTANEOUS LYMPHOMA TASK FORCE OF THE EUROPEAN ORGANIZATION OF RESEARCH AND TREATMENT OF CANCER; GENETIC ANALYSIS; HEALTH CARE ORGANIZATION; HUMAN; INTERNATIONAL SOCIETY FOR CUTANEOUS LYMPHOMAS; MEDICAL RESEARCH; MOLECULAR IMAGING; MYCOSIS FUNGOIDES; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REVIEW; SEZARY SYNDROME; SKIN EXAMINATION; SKIN LYMPHOMA; STANDARDIZATION;

EID: 34547112311     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-10-054601     Document Type: Review

References (15)

1. UICC. TNM Classification of Malignant Tumors (ed Sixth). New York: Wiley-Liss; 2002.
2. AJCC. AJCC Cancer Staging Manual (ed Sixth). New York: Springer; 2002.
3. Project TIN-HsLPF. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993;329:987-994.
4. Bunn P, Lamberg S. Report of the committee on staging and classification of cutaneous T-cell lymphomas. Cancer Treat Rep. 1979;63:725-728.
5. Kim Y, Liu H, Mraz-Gernhard S, Varghese A, Hoppe R. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome. Arch Dermatol. 2003;139:857-866.
6. Willemze R, Jaffe E, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768-3785.
7. Grange F, Hedelin G, Joly P, et al. Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sezary syndrome. Blood. 1999;93:3637-3642.
8. Bekkenk M, Geelen F, van Voorst Vader P, et al. Primary and secondary cutaneous CD30+ lymphoproliferative disorders: a report from the Dutch cutaneous lymphoma group on the longterm follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood. 2000;95:3653-3661.
9. Liu H, Hoppe R, Kohler S, Harvell J, Reddy S, Kim Y. CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma. J Am Acad Dermatol. 2003;49:1049-1058.
10. Juweid M, Cheson B. Role of positron emission tomography in lymphoma. J Clin Oncol. 2005;23:4577-4580.
11. Juweid M, Wiseman G, Vose J, et al. Response assessment of aggressive non-Hodgkin's lymphoma by integrated international workshop criteria and fluorine-18-fluorodeoxyglucose positron emission tomography. J Clin Oncol. 2005;23:4652-4661.
12. Juweid M, Cheson B. Positron-emission tomography and assessment of cancer therapy. N Engl J Med. 2006;354:496-507.
13. Tsai E, Taur A, Espinosa L, et al. Staging accuracy in mycosis fungoides and Sezary syndrome using integrated positron emission tomography and computed tomography. Arch Dermatol. 2006;142:577-584.
14. Cheson B, Horning S, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. J Clin Oncol. 1999;17:1244-1253.
15. Armitage J. Staging non-Hodgkin lymphoma. CA Cancer J Clin. 2005;55:368-376.